Difference between revisions of "Tyrosine kinase inhibitors"
Jump to navigation
Jump to search
(create) |
(redirect) |
||
| Line 9: | Line 9: | ||
*[[Epidermal growth factor receptor inhibitors]]. | *[[Epidermal growth factor receptor inhibitors]]. | ||
*[[Cancer drugs]]. | *[[Cancer drugs]]. | ||
*[[Lung adenocarcinoma]]. | |||
[[Category:Clinical]] | [[Category:Clinical]] | ||
Revision as of 18:55, 27 April 2012
Tyrosine kinase inhibitors, abbreviated TKIs, are a group of drugs that inhibit the action of tyrosine kinases.
The category includes many cancer drugs - including:
- Imatinib (Gleevec).
- Gefitinib (Iressa).
- Erlotinib (Tarceva).